Vaxine Pty Ltd   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Beford Park Australia (2002)

Organization Overview

First Clinical Trial
2013
NCT01951677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Vaxine Pty Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bites and Stings (Phase 2)

Coronavirus Infections (Phase 1)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Herpesviridae Infections (Phase 2)

Influenza, Human (Phase 1)

Influenza in Birds (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 9